Literature DB >> 25053348

The effect of different drugs on the preparation and biological outcomes of plasma rich in growth factors.

Eduardo Anitua1, María Troya2, Mari Mar Zalduendo2, Gorka Orive3.   

Abstract

Chronic diseases are the major contributors to the global burden of disease and involve prodigious consumption of various drugs that usually affect platelet function. The autologous technology of plasma rich in growth factors (PRGF) provides a biological approach using autologous platelets as a reservoir and local delivery of proteins to promote tissue healing. The purpose of this study was to evaluate the effect of the consumption of acetylsalicylic acid, acenocoumarol and glucosamine sulfate on the preparation as well as on the biological properties of the PRGF technology. Clotting time and platelet activation of PRGF was evaluated. The latter was performed by flow cytometry. PRGF growth factor content and the release of various biomolecules by gingival fibroblasts were quantified by enzyme-linked immunosorbent assay. Cell proliferation was evaluated by means of a fluorescence-based method and cell migration was performed on culture inserts. None of the parameters evaluated was modified by the consumption of any of the three drugs tested; only the plasma of patients who had consumed acetylsalicylic acid and acenocoumarol expressed greater gingival fibroblast migration compared to plasma control. The intake of acetylsalicylic acid, acenocoumarol and glucosamine sulfate does not alter the preparation and biological properties of the autologous technology of PRGF.

Entities:  

Keywords:  Acenocoumarol; Acetylsalicylic acid; Gingival fibroblasts; Glucosamine sulfate; Growth factors; Plasma rich in growth factors

Mesh:

Substances:

Year:  2014        PMID: 25053348     DOI: 10.1016/j.aanat.2014.06.002

Source DB:  PubMed          Journal:  Ann Anat        ISSN: 0940-9602            Impact factor:   2.698


  5 in total

Review 1.  Clinical Update: Why PRP Should Be Your First Choice for Injection Therapy in Treating Osteoarthritis of the Knee.

Authors:  Corey S Cook; Patrick A Smith
Journal:  Curr Rev Musculoskelet Med       Date:  2018-12

Review 2.  Effects of Antiplatelet and Nonsteroidal Anti-inflammatory Medications on Platelet-Rich Plasma: A Systematic Review.

Authors:  Christopher Frey; Peter Chia Yeh; Prathap Jayaram
Journal:  Orthop J Sports Med       Date:  2020-04-29

3.  Regenerative Medicine, Stem Cell Therapies, and Platelet-Rich Plasma: Where Is the Evidence?

Authors:  Naveen Virin Goddard; Norman Waterhouse
Journal:  Aesthet Surg J       Date:  2020-03-23       Impact factor: 4.283

4.  Parecoxib alleviates the inflammatory effect of leukocyte-rich platelet-rich plasma in normal rabbit tendons.

Authors:  Ming Zhou; Ning Wang; Gang Wang; Zishan Jia; Xiaolei Qi
Journal:  BMC Musculoskelet Disord       Date:  2020-12-10       Impact factor: 2.362

Review 5.  Is Antiplatelet Therapy Contraindicated After Platelet-Rich Plasma Treatment? A Narrative Review.

Authors:  Matthew Magruder; Scott A Rodeo
Journal:  Orthop J Sports Med       Date:  2021-06-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.